A Comprehensive Psychometric Validation of EQ Instruments for Early Childhood Health-Related Quality of Life and Caregiver Spillover
A Comprehensive Psychometric Validation of EQ Instruments for Early Childhood Health-Related Quality of Life and Caregiver Spillover, Including EQ-TIPS, EQ-5D-Y-5L, EQ-5D-5L With Sleep and Fatigue Bolt-ons, and the EQ-HWB-9
This study aims to address critical gaps in the measurement of health-related quality of life (HRQoL) in children under the age of five by conducting a comprehensive psychometric validation of the EQ-TIPS instrument, including both 3-level and 5-level versions. We will conduct a longitudinal study using both quantitative and qualitative methods to assess the feasibility, face validity, known-groups validity, test-retest reliability, and responsiveness of both EQ-TIPS-3L and EQ-TIPS-5L in children aged 0-48 months. For children aged 25-48 months, we will also examine the comparability and potential transition between EQ-TIPS-5L and the proxy version of EQ-5D-Y-5L. In addition, we aim to explore spillover effects on family carers by evaluating the psychometric performance, such as known-groups validity, test-retest reliability, and responsiveness of two newly developed EQ-5D-5L bolt-on items (sleep and fatigue) and the EQ-HWB-9. A total of 450 participants will be recruited from three tertiary hospitals in China across three health condition groups: acute illnesses (n=180), chronic conditions (n=180), and healthy controls (n=90), with an approximately balanced distribution across age groups and disease severity levels. The survey questionnaires will include two parts: 1) Child section: EQ-TIPS-3L, EQ-TIPS-5L, proxy EQ VAS, EQ-5D-Y-5L proxy version 1 (only for children aged 25-48 months), a 5-grade overall health assessment (OHA) proxy version, QQ-10 questionnaire, and children's demographic information; 2) Carer section: carers' EQ-5D-5L with sleep and fatigue bolt-ons, carers' EQ VAS, carers' EQ-HWB-9, and carers' demographic information. Each clinical condition is selected for its high prevalence and clinical relevance in early childhood, as well as its suitability for stratifying health status by severity. Additionally, to assess face validity, carers will complete the QQ-10 questionnaire after completing the EQ-TIPS questionnaire to provide structured feedback on the clarity, relevance, and acceptability of EQ-TIPS. Findings will contribute essential evidence to support the use of EQ-TIPS in early childhood HRQoL assessment and of the EQ-5D-5L bolt-ons and EQ-HWB-9 in evaluating caregiver spillover effects. The study data will be shared with the EuroQol Group to support future development and application of these instruments.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (추정된)
등록
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Wenjing Zhou, PhD
- 전화번호: 86-13817114768
- 이메일: zhoujing2188@163.com
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
The study population will consist of 450 children aged 0-48 months and their primary family carers recruited from three tertiary hospitals in China. Participants will be enrolled into three groups: acute illnesses (pneumonia and diarrhoea, n=180), chronic conditions (haematological malignancies and asthma, n=180), and healthy controls (n=90). Recruitment will aim for balanced representation across age groups (0-24 and 25-48 months) and disease severity levels. Children with illnesses will be recruited from outpatient clinics and inpatient departments, while healthy controls will be recruited during routine physical examinations. Primary family carers will serve as proxy respondents for child health assessments and complete questionnaires assessing their own health and well-being.
설명
Inclusion Criteria:
- -Children aged 0-48 months at enrolment.
- Children diagnosed with pneumonia, acute diarrhoea, haematological malignancies, or asthma; or healthy children without known medical conditions attending routine physical examinations.
- Availability of a primary family carer (parent, grandparent, or legal guardian) who has primarily cared for the child during the preceding month, including supervision of daily activities and health-related care.
- The primary family carer accompanies the child during the outpatient visit, inpatient admission, or routine physical examination.
- The primary family carer is able to understand the study information and provides written informed consent.
Exclusion Criteria:
- Children older than 48 months at enrolment.
- Primary family carers unable to read or understand Chinese.
- Primary family carers with cognitive impairments that prevent questionnaire completion.
- Absence of written informed consent.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: PROSPECTIVE
그룹/코호트 수
코호트 및 개입
그룹/코호트그룹/코호트 |
개입 / 치료개입 / 치료 |
|---|---|
|
Acute Illness Group
Children aged 0-48 months diagnosed with acute illnesses, including pneumonia (n=90) and acute diarrhoea (n=90). Participants will be recruited across different disease severity levels. Their primary family carers will complete proxy-reported health-related quality of life assessments at baseline and follow-up, while also reporting their own health and well-being. |
This study involves longitudinal health-related quality of life assessments of children aged 0-48 months and their primary family carers. Carers will complete the EQ-TIPS-3L and EQ-TIPS-5L as proxy respondents for their children. For children aged 25-48 months, the proxy EQ-5D-Y-5L will also be administered. Carers will additionally complete the EQ-5D-5L with sleep and fatigue bolt-on items and the EQ-HWB-9 to assess caregiver spillover effects. Assessments will be conducted at baseline and follow-up using tablet-based questionnaires. No therapeutic interventions will be assigned as part of the study. |
|
Chronic Illness Group
Children aged 0-48 months diagnosed with chronic conditions, including haematological malignancies (n=90) and asthma (n=90). Participants will represent different levels of disease severity. Their primary family carers will complete proxy-reported health-related quality of life assessments at baseline and follow-up, alongside assessments of their own health and caregiver spillover effects |
This study involves longitudinal health-related quality of life assessments of children aged 0-48 months and their primary family carers. Carers will complete the EQ-TIPS-3L and EQ-TIPS-5L as proxy respondents for their children. For children aged 25-48 months, the proxy EQ-5D-Y-5L will also be administered. Carers will additionally complete the EQ-5D-5L with sleep and fatigue bolt-on items and the EQ-HWB-9 to assess caregiver spillover effects. Assessments will be conducted at baseline and follow-up using tablet-based questionnaires. No therapeutic interventions will be assigned as part of the study. |
|
Healthy Control Group
Group/Cohort Description: Age-matched healthy children aged 0-48 months (n=90), with no known medical conditions at the time of assessment, recruited during routine physical examinations. Their primary family carers will complete the same proxy-reported child health and caregiver health-related quality of life assessments as those in the illness groups. |
This study involves longitudinal health-related quality of life assessments of children aged 0-48 months and their primary family carers. Carers will complete the EQ-TIPS-3L and EQ-TIPS-5L as proxy respondents for their children. For children aged 25-48 months, the proxy EQ-5D-Y-5L will also be administered. Carers will additionally complete the EQ-5D-5L with sleep and fatigue bolt-on items and the EQ-HWB-9 to assess caregiver spillover effects. Assessments will be conducted at baseline and follow-up using tablet-based questionnaires. No therapeutic interventions will be assigned as part of the study. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Known-Groups Validity of EQ-TIPS-3L and EQ-TIPS-5L
기간: Baseline
|
Known-groups validity will be evaluated by comparing EQ-TIPS-3L and EQ-TIPS-5L level sum scores (LSS) across predefined clinical severity categories and overall health assessment (OHA) categories. Cohen's d and relative efficiency based on ANOVA F-statistics will be calculated to assess the instruments' discriminatory ability. |
Baseline
|
|
Test-Retest Reliability of EQ-TIPS-3L and EQ-TIPS-5L
기간: Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)
|
Test-retest reliability will be evaluated among children whose health status remains stable between baseline and follow-up, as determined by unchanged clinical severity and overall health assessment (OHA). Intraclass correlation coefficients (ICCs) will be calculated for EQ-TIPS level sum scores (LSS), and Gwet's agreement coefficients will be calculated for individual dimensions. |
Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)
|
|
Responsiveness of EQ-TIPS-3L and EQ-TIPS-5L to Changes in Child Health
기간: Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)
|
Responsiveness will be evaluated by changes in EQ-TIPS-3L and EQ-TIPS-5L scores between baseline and follow-up among children classified as improved, stable, or deteriorated based on clinical indicators and overall health assessment (OHA). Standardised effect size (SES), standardised response mean (SRM), and Paretian Classification of Health Change (PCHC) will be calculated. |
Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Face Validity and Acceptability of EQ-TIPS-3L and EQ-TIPS-5L
기간: Baseline
|
Face validity and acceptability will be assessed using the QQ-10 questionnaire completed by family carers. Quantitative responses will evaluate perceived value, clarity, relevance, and acceptability. Open-ended responses will undergo thematic content analysis to identify concerns regarding comprehensiveness, redundancy, and questionnaire burden. |
Baseline
|
|
Comparative Psychometric Performance of EQ-TIPS-3L and EQ-TIPS-5L
기간: Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)
|
EQ-TIPS-3L and EQ-TIPS-5L will be compared in terms of missing responses, response distributions, ceiling effects, known-groups validity, test-retest reliability, and responsiveness to health change. Ceiling effects will be assessed using the proportion of children reporting no problems across all dimensions. |
Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)
|
|
Psychometric Performance of EQ-5D-5L With Sleep and Fatigue Bolt-Ons and EQ-HWB-9 in Family Carers
기간: Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)
|
Caregiver outcomes will be evaluated using EQ-5D-5L with sleep and fatigue bolt-on items and EQ-HWB-9. Analyses will assess response distributions, ceiling effects, known-groups validity, test-retest reliability, and responsiveness to changes in child health. Regression analyses will explore associations with child disease severity, caregiving time, and caregiver burden. |
Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)
|
공동 작업자 및 조사자
협력자
협력자
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- EQ Project 2152-RA
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .